PROVIDER PROFILE · NPI 1720036767

Isidora KafkasPA-C

PRESCRIBING · PART D · 2024
Total Rx claims
35
Beneficiaries
—
Total drug cost
$4K
Distinct drugs
3
Brand share
0.0%
Top prescribed drugs
Droxidopa12 claims
Gabapentin12 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
75.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.42%
Group